Anxiety and depression Anxiety and depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: • >= 18 years of age • Main diagnosis of anxiety disorder (social anxiety disorder (300.23), panic disorder (300.01), agoraphobia (300.22), generalized anxiety disorder (300.02), other specified anxiety disorder (300.9), obsessive-compulsive disorder/hoarding disorder (300.3), and illness anxiety disorder (300.7)), and/or depressive disorder (major depressive disorder with single or recurrent episodes (296.20 - 296-36) and other specified depressive mood disorders (311)) • Being able to understand, read, and speak Dutch or English • Having access to the internet and a smartphoneTherapists: Therapists can participate in the surveys if they are treating participating patients as part of this study. Moreover, therapist can be included in the optional qualitative interview when they are willing to participate in both interviews (i.e., one in the beginning of the study and one 9 months thereafter).
Exclusion criteria
Exclusion criteria: Patients:• Known severe psychiatric comorbidity (e.g., psychosis, (severe) addiction that interferes with daily functioning, diagnosis of Bipolar Disorder I or II, eating disorder, Personality Disorders, traumatic brain injury, Intellectual Disability and/or General Medical Conditions with a life expectancy of less than one year) • Severe or very severe level of Suicidality (preparing for suicide, recent suicide attempt) • Having received psychological treatment in the prior 6 months for the same anxiety or mood disorder (except for short-term treatment provided by POH-GGZ or student psychologist) • Therapist judges that the patient is not suitable for receiving DST • Not being able to complete the entire treatment at once (e.g., due to pregnancy).Therapists: There are no specific exclusion criteria for therapists.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoints are the effectiveness and cost-effectiveness of the DST. The effectiveness of the DST will be measured by analyzing anxiety and depression symptoms, general mental-health-related symptoms and functioning, and quality of life. To determine the cost-effectiveness, we will look at the costs related to the intervention, the use of healthcare resources (e.g., the use of medication), and productivity losses. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Acceptability of DST (CSQ-8) - Feasibility of DST (usage data) - Patient-centered care (therapeutic working alliance [WAI-SF], shared decision making from patient perspective [collaboRATE survey] - Patient empowerment [NEL] - Client functioning (OMQ, SMQ) | — |
Countries
Netherlands
Contacts
Leids Universitair Medisch Centrum